Physician profile
Benjamin Thomas Neltner
NPI 1922531680
$373.02
in general payments reported to CMS, 2019-2025
10 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.72 · 2023: $109 · 2024: $34.04 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.30 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $123.13 | 2022-2025 | Ozempic |
| Biomerieux INC | $69.51 | 2025 | |
| Glaxosmithkline, LLC. | $40.57 | 2023-2025 | Trelegy Ellipta |
| Currax Pharmaceuticals LLC | $40.09 | 2023-2025 | Nexletol, Contrave |
| Novartis Pharmaceuticals Corporation | $22.56 | 2025 | |
| Amgen INC. | $18.33 | 2025 | Evenity |
| Azurity Pharmaceuticals, INC. | $16.40 | 2025 | Edarbi |
| Lilly USA, LLC | $15.53 | 2025 | Zepbound, Mounjaro |
| Pfizer INC. | $13.89 | 2025 | |
| Exact Sciences Corporation | $13.01 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Neltner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.